297 related articles for article (PubMed ID: 30079141)
1. Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data.
Chand M; Keller DS; Mirnezami R; Bullock M; Bhangu A; Moran B; Tekkis PP; Brown G; Mirnezami A; Berho M
World J Gastrointest Oncol; 2018 Jul; 10(7):145-158. PubMed ID: 30079141
[TBL] [Abstract][Full Text] [Related]
2. The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer.
Taieb J; Jung A; Sartore-Bianchi A; Peeters M; Seligmann J; Zaanan A; Burdon P; Montagut C; Laurent-Puig P
Drugs; 2019 Sep; 79(13):1375-1394. PubMed ID: 31347092
[TBL] [Abstract][Full Text] [Related]
3. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis.
Søreide K; Watson MM; Lea D; Nordgård O; Søreide JA; Hagland HR;
J Transl Med; 2016 Jun; 14(1):192. PubMed ID: 27357108
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
[TBL] [Abstract][Full Text] [Related]
5. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
7. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F
Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124
[TBL] [Abstract][Full Text] [Related]
8. Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.
Li Q; Xiao X; Feng J; Yan R; Xi J
Front Endocrinol (Lausanne); 2023; 14():1196094. PubMed ID: 37404304
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer.
Christodoulou S; Sotiropoulou CD; Vassiliu P; Danias N; Arkadopoulos N; Sideris DC
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373137
[TBL] [Abstract][Full Text] [Related]
10. Potential of
Habiburrahman M; Wardoyo MP; Sutopo S; Rahadiani N
Mol Clin Oncol; 2022 Jul; 17(1):117. PubMed ID: 35747597
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancer.
Qu X; Tan H; Mao J; Yang M; Xu J; Yan X; Wu W
Cancer Med; 2023 Mar; 12(5):5926-5938. PubMed ID: 36281556
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in colorectal cancer: potential biomarkers and therapeutic targets.
Yan S; Cao Y; Mao A
Front Biosci (Landmark Ed); 2015 Jun; 20(7):1092-103. PubMed ID: 25961547
[TBL] [Abstract][Full Text] [Related]
14. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
[TBL] [Abstract][Full Text] [Related]
15. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
[TBL] [Abstract][Full Text] [Related]
16. The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent.
Ahadi A
Noncoding RNA Res; 2020 Sep; 5(3):125-134. PubMed ID: 32954092
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening-A Comprehensive Review.
Santos DAR; Gaiteiro C; Santos M; Santos L; Dinis-Ribeiro M; Lima L
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446201
[TBL] [Abstract][Full Text] [Related]
18. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
[TBL] [Abstract][Full Text] [Related]
19. Integrated analyses of microRNA-29 family and the related combination biomarkers demonstrate their widespread influence on risk, recurrence, metastasis and survival outcome in colorectal cancer.
Peng Q; Feng Z; Shen Y; Zhu J; Zou L; Shen Y; Zhu Y
Cancer Cell Int; 2019; 19():181. PubMed ID: 31346316
[TBL] [Abstract][Full Text] [Related]
20. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer.
Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q
Gene; 2020 Sep; 754():144899. PubMed ID: 32544494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
